ALBT — Avalon Globocare Share Price
0.000.00%
Last trade - 00:00- $6.13m
- $34.60m
- $1.33m
- 36
- 20
- 28
- 17
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.6 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -81.18% | ||
| Return on Equity | n/a | ||
| Operating Margin | -432.47% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 1.38 | 1.39 | 1.2 | 1.26 | 1.33 | n/a | n/a | -2.92% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Directors
- Wenzhao Lu CHM (63)
- David Jin PRE (53)
- Luisa Ingargiola CFO (52)
- Meng Li COO (43)
- Wilbert Tauzin DRC (77)
- Yue Li IND (47)
- Yancen Lu IND (46)
- Steven Sanders IND (75)
- William Stilley IND (53)
- Tevi Troy IND (53)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 28th, 2014
- Public Since
- February 22nd, 2016
- No. of Shareholders
- 237
- No. of Employees
- 5
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- NASDAQ Capital Market
- Shares in Issue
- 1,651,667
- Address
- 4400 ROUTE 9, SUITE 3100, FREEHOLD, 07728
- Web
- https://www.avalon-globocare.com/
- Phone
- +1 7327804400
- Auditors
- M&K CPAS, PLLC
Upcoming Events for ALBT
Avalon Globocare Corp Annual Shareholders Meeting
Similar to ALBT
Accelerate Diagnostics
NASDAQ Capital Market
Adagio Medical Holdings
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Avalon Globocare share price?
As of Today at 19:26 UTC, shares in Avalon Globocare are trading at $3.71. This share price information is delayed by 15 minutes.
How has the Avalon Globocare share price performed this year?
Shares in Avalon Globocare last closed at $3.71 and the price had moved by -11.67% over the past 365 days. In terms of relative price strength the Avalon Globocare share price has underperformed the S&P500 Index by -18.47% over the past year.
What are the analyst and broker recommendations for Avalon Globocare?
There is no consensus recommendation for this security.
Find out moreWhat is the Avalon Globocare dividend yield?
Avalon Globocare does not currently pay a dividend.
Does Avalon Globocare pay a dividend?
Avalon Globocare does not currently pay a dividend.
When does Avalon Globocare next pay dividends?
Avalon Globocare does not currently pay a dividend.
How do I buy Avalon Globocare shares?
To buy shares in Avalon Globocare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Avalon Globocare?
As of the previous close price of $3.71, shares in Avalon Globocare had a market capitalisation of $6.13m.
Where are Avalon Globocare shares listed?
Here are the trading details for Avalon Globocare:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: ALBT
What kind of share is Avalon Globocare?
Based on an overall assessment of its quality, value and momentum Avalon Globocare is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Avalon Globocare share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Avalon Globocare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Avalon Globocare. Over the past six months, its share price has outperformed the S&P500 Index by +13.34%.
As of the last closing price of $3.71, shares in Avalon Globocare were trading -12.42% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Avalon Globocare PE Ratio?
The Avalon Globocare PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $3.71.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Avalon Globocare?
Avalon Globocare's management team is headed by:
- Wenzhao Lu - CHM
- David Jin - PRE
- Luisa Ingargiola - CFO
- Meng Li - COO
- Wilbert Tauzin - DRC
- Yue Li - IND
- Yancen Lu - IND
- Steven Sanders - IND
- William Stilley - IND
- Tevi Troy - IND